Go Pro

California State Teachers Retirement System Has $27.27 Billion Stock Holdings in Humana Inc. $HUM

Humana logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • California State Teachers Retirement System dramatically increased its Humana stake by 39,982.9% in the second quarter, owning 68.64 million shares valued at approximately $27.27 billion, or 57.17% of the company.
  • Analyst sentiment is mixed but improving: Humana has an overall “Hold” consensus rating and a $403.91 average price target, while several firms recently raised their targets or upgraded the stock.
  • Humana reported quarterly adjusted earnings of $7.61 per share, beating estimates, while revenue rose 26.2% year over year to $40.89 billion. The company also declared a quarterly dividend of $0.885 per share, implying a 0.9% annual yield.
  • MarketBeat previews top five stocks to own in October.

California State Teachers Retirement System raised its stake in Humana Inc. (NYSE:HUM - Free Report) by 39,982.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 68,644,780 shares of the insurance provider's stock after purchasing an additional 68,473,523 shares during the period. California State Teachers Retirement System owned 57.17% of Humana worth $27,267,080,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Wilkerson Advisory Group LLC increased its position in Humana by 24.6% in the second quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider's stock worth $66,000 after buying an additional 33 shares during the last quarter. Bogart Wealth LLC lifted its position in shares of Humana by 192.0% during the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider's stock valued at $29,000 after buying an additional 48 shares during the last quarter. Fiduciary Alliance LLC grew its stake in shares of Humana by 0.9% during the 1st quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider's stock worth $976,000 after acquiring an additional 49 shares during the period. Johnson Financial Group Inc. bought a new position in shares of Humana during the 2nd quarter worth $26,000. Finally, CoreCap Advisors LLC increased its holdings in Humana by 74.7% in the 2nd quarter. CoreCap Advisors LLC now owns 159 shares of the insurance provider's stock worth $63,000 after acquiring an additional 68 shares during the last quarter. Institutional investors own 92.38% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. Mizuho boosted their price objective on Humana from $335.00 to $390.00 and gave the company an "outperform" rating in a research note on Monday, June 8th. JPMorgan Chase & Co. lifted their target price on shares of Humana from $316.00 to $393.00 and gave the stock a "neutral" rating in a research note on Monday, August 10th. Piper Sandler upgraded shares of Humana from a "hold" rating to an "overweight" rating and set a $463.00 target price for the company in a research note on Thursday, July 30th. Weiss Ratings upgraded shares of Humana from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, August 14th. Finally, Bank of America raised shares of Humana from a "neutral" rating to a "buy" rating and set a $500.00 price objective for the company in a report on Wednesday, July 29th. Fourteen research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $403.91.

Check Out Our Latest Analysis on HUM

Humana Price Performance

HUM stock opened at $400.70 on Tuesday. The firm has a 50 day moving average of $388.67 and a 200-day moving average of $298.31. The firm has a market capitalization of $48.12 billion, a P/E ratio of 37.91, a price-to-earnings-growth ratio of 2.63 and a beta of 0.74. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $428.88. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts' consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same quarter in the prior year, the firm posted $6.27 EPS. Humana's revenue was up 26.2% on a year-over-year basis. As a group, sell-side analysts predict that Humana Inc. will post 9 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Friday, October 30th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, October 30th. Humana's dividend payout ratio (DPR) is 33.49%.

About Humana

(Free Report)

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

See Also

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Humana Right Now?

Before you consider Humana, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.

While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines